- Open almost any pharma resource library and the default is still a PDF. Meanwhile the physician clicking through it just finished watching a video explainer on something else.
- 63% of the time, physicians read only the abstract of a publication. Video doesn’t ask a physician to read the whole paper to reach the point.
- The honest objection is that video is slow and expensive, and every version needs its own review. Building the story once, at the source, is what changes that math.
Physicians already learn by video everywhere else. Pharma content is often the exception. Here's what we found, and what it means for how you build your next story.
01The format physicians didn’t choose
Open almost any pharma resource library and the default is still a PDF. Meanwhile the physician clicking through it just finished watching a video explainer on something else entirely.
of the time, physicians read only the abstract of a publication, not the full paper.
MLR review covers every version, however many journeys one approved core holds.
languages one approved core is produced in, without restarting the scientific review each time.
Every figure here is independently sourced.
02What gets lost in translation
63% of the time, physicians read only the abstract of a publication. Video doesn’t ask a physician to choose between the abstract and the rest, it can carry the mechanism and the clinical implication in the same two minutes.
“The only thing standing between your publication and her attention has been the format, not her interest in the science.”
03Why teams hesitate anyway
The honest objection is that video is slow and expensive, and every version needs its own review. That's the part we changed. One approved scientific core becomes the visual story, and one MLR review covers it.
04Meeting physicians where they already are
She already prefers video. The only thing standing between your publication and her attention has been the format, not her interest in the science.